References
- http://online.wsj.com/article/SB10001424052702304818404577345953943484054.html?_nocache=1355097541425&user=welcome&mg =id-wsj#articleTabs%3Darticle
- http://abcnews.go.com/Health/Wellness/lou-gehrigs-disease-patients-research-hands/story?id=16150103#.UMUnRKUz20s
- http://www.economist.com/blogs/babbage/2012/05/self-medication
- Graber D, Hickey W, Harris R. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflammation. 2010;7:8.
- Lincecum J, Viera F, Wang M, Thompson K, de Zutter G, Kid J, . From transcriptome analysis to therapeutic anti-CD40L treatment in SOD1 model of amyotrophic lateral sclerosis. Nat Genet. 2010;42:392–9.
- Turner M, Cagnin A, Turkheimer F, Miller C, Shaw C, Brooks D, . Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C]®-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601–9.
- Zhang R, Gascon R, Miller R, Gelinas D, Mass J, Hadlock K, . Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis. J Neuroimmunol. 2005;159:215–24.
- Brettschneider J, Toledo J, van Deerlin V, Elman L, McClusley L, Lee V, Trojanowski J. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in patients with amyotrophic lateral sclerosis. PLoS One. 20132;7:39216.
- http://www.neuraltus.com/pages/programs.html#np001
- Miller R, Block G, Gopalakrishnan V, McGrath M, Study Group NP001. Phase II safety and efficacy of NP001: a novel immune regulator for ALS. Amyotroph Lateral Scler. 2012;13(Suppl 1):28.
- http://www.neuraltus.com/pages/news_rel10_30_12.html
- Personal communication from Dr. M. McGrath 2012.
- http://www.als.net/forum/yaf_postst4941p2_Oral-Sodium-Chlorite.aspx
- McGrath M, Kahn J, Herndier B. Development of WF10, a novel macrophage-regulating agent. Curr Opin Investig Drugs. 2002;3:365–73.
- www.oxothai.com/
- http://www.mndassociation.org/Resources/MNDA/Migrated%20Resources/Documents/W/Work%20in%20progress%20and%20care%20practice%20(606)_2149.pdf
- Personal communication from Eric Valor 2013
- James H, Timothy V, Paul W. Waiting for p < 0.05. figshare. Retrieved 00:54, Jan 02, 2013 (GMT)http://dx.doi.org/10.6084/m9.figshare.96802
- http://www.patientslikeme.com/treatment_evaluations/browse?attribute=efficacy&condition_id=9&id=21969-wf10-side-effects-and-efficacy&value=4
- http://www.patientslikeme.com/treatment_evaluations/browse?attribute = efficacy&brand = f&condition_id=9&id= 21969-wf10-side-effects-and-efficacy&value=2
- http://www.patientslikeme.com/treatment_evaluations/85153
- Veerasarn V, Khorprasert C, Lorvidhaya V, Sangruchi S, Tantivatana T, Narkwong L, . Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients a multicenter, randomized, two-arm, open-label trial. Radiotherapy and Oncology. 2004;73: 179–85.
- http://www.patientslikeme.com/treatments/show/21969-wf10-side-effects-and-efficacy#overview
- http://www.alsnet/Forum/?g = search, postings by Happy Physicist and Elysee Reclus dated 1/21/12.
- http://www.als.net/forum/yaf_postst49413p2_Oral-Sodium-Chlorite.aspx
- https://sites.google.com/site/alschlorite/documents
- Abdel-Rahman M, Couri D, Bull R. Metabolism and pharmacokinetics of alternate drinking water disinfectants. Environmental Health Perspectives. 1982;46:19–23.
- Bercz JP, Jones L, Garner L, Murray D, Ludwig D, Boston J. Subchronic toxicity of chlorine dioxide and related compounds in the non-human primate. Environmental Health Perspect. 1982;46:47–55.
- Personal communication with Dr. F. W. Kuehne 2012.
- Lubbers J, Chauan S, Bianchine J. Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man. Environmental Health Perspectives. 1982;46:57–62.
- https://www.patientslikeme.com/treatments/show/22322-sodium-chlorite-side-effects-and-efficacy?brand=f#overview
- https://www.patientslikeme.com/treatment_evaluations/browse?condition_id=9&id=22322-sodium-chlorite-side-effects-and-efficacy